Wingrove Theresa's Form 4 filing
ImmunoGen, Inc. (IMGN) · filed Oct 18, 2023
- Accession no.
- 0001415889-23-014404
- Filed
- Oct 18, 2023
- Trade date
- Oct 16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.76M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wingrove TheresaCIK 0001510720 | Officer (SVP OF REGULATORY AFFAIRS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Common Stock | MOption exerciseAcquired | +158,641 | $4.55 | +$721,816.55 | 161,452 | Direct | |
| Oct 16, 2023 | Common Stock | MOption exerciseAcquired | +33,363 | $4.55 | +$151,801.65 | 194,815 | Direct | |
| Oct 16, 2023 | Common Stock | SSaleDisposed | −192,004 | $14.40 | −$2,764,857.6 | 2,811 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Common Stock | MOption exerciseDisposed | −158,641 | $0.00 | $0 | 63,659 | Direct | |
| Oct 16, 2023 | Common Stock | MOption exerciseDisposed | −33,363 | $0.00 | $0 | 208,406 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.